Ahmad Shahzaib1*, Tabish Raza2 and Aisha Areej2
...e latest reports of high mucormycosis mortality and disease severity in India raise global concerns. Several studies have been reported that describe different levels of superinfections and disease severity in COVID-19 patients. Perhaps, there is just not enough data to distinguish between the worst outcomes of COVID-19 alone and coinfections, particularly when it comes to CS. Current clinical use of immunosuppressive therapies, including cytokine blockade, JA...
